Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis

E

EGBOT

Guest
Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis

HTML:
Anika Therapeutics, Inc.,, a leader in products for tissue protection, healing, and repair based on hyaluronic acid technology, today reported positive results from the CINGAL 13-02 study evaluating the safety of a repeat injection of Cingal for symptomatic relief of osteoarthritis  of the knee.

Source: Anika Therapeutics announces positive results from CINGAL phase 3 trial for knee osteoarthritis
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

Latest threads

Back
Top